IGMS
IGM Biosciences
IGMS
IGMS
Delisted
IGMS was delisted on the 13th of August, 2025.
104 hedge funds and large institutions have $1.36B invested in IGM Biosciences in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 38 increasing their positions, 32 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
5% less funds holding
Funds holding: 109 → 104 (-5)
6.79% less ownership
Funds ownership: 70.61% → 63.83% (-6.8%)
22% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 23
Holders
104
Holding in Top 10
2
Calls
$4.54M
Puts
$2.89M
Top Buyers
| 1 | +$26.2M | |
| 2 | +$15.8M | |
| 3 | +$6.96M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$5.83M |
| 5 |
BC
Bruce & Co
Chicago,
Illinois
|
+$4.58M |
Top Sellers
| 1 | -$75.4M | |
| 2 | -$26.4M | |
| 3 | -$22.5M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$20.6M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$20.4M |